Literature DB >> 17553602

Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.

Katrin S Kohl1, Wikke Walop, Jane Gidudu, Leslie Ball, Scott Halperin, Sandra Jo Hammer, Paul Heath, Renald Hennig, Edward Rothstein, Anne Schuind, Frederick Varricchio.   

Abstract

Mesh：

Year:  2007        PMID： 17553602     DOI： 10.1016/j.vaccine.2007.04.062

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  10 in total

1.  Sixty-four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium-adsorbed vaccines-prognosis and outcome after booster vaccination.

Authors:  Elisabet Bergfors; Birger Trollfors
Journal:  Eur J Pediatr       Date:  2012-10-11       Impact factor: 3.183

2.  Template protocol for clinical trials investigating vaccines--focus on safety elements.

Authors:  Jan Bonhoeffer; Egeruan B Imoukhuede; Grace Aldrovandi; Novilia S Bachtiar; Eng-Soon Chan; Soju Chang; Robert T Chen; Rohini Fernandopulle; Karen L Goldenthal; James D Heffelfinger; Shah Hossain; Indira Jevaji; Ali Khamesipour; Sonali Kochhar; Mamodikoe Makhene; Elissa Malkin; David Nalin; Rebecca Prevots; Ranjan Ramasamy; Sarah Sellers; Johan Vekemans; Kenneth B Walker; Pam Wilson; Virginia Wong; Khalequz Zaman; Ulrich Heininger
Journal:  Vaccine       Date:  2013-03-13       Impact factor: 3.641

3.  The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule.

Authors:  Kusnandi Rusmil; Hartono Gunardi; Eddy Fadlyana; Meita Dhamayanti; Rini Sekartini; Hindra Irawan Satari; Nelly Amalia Risan; Dwi Prasetio; Rodman Tarigan; Reni Garheni; Mia Milanti; Sri Rezeki Hadinegoro; Suganda Tanuwidjaja; Novilia Sjafri Bachtiar; Rini Mulia Sari
Journal:  BMC Pediatr       Date:  2015-12-19       Impact factor: 2.125

Review 4.  Vaccination in elite athletes.

Authors:  Barbara C Gärtner; Tim Meyer
Journal:  Sports Med       Date:  2014-10       Impact factor: 11.136

5.  Statistical analysis plan for the OPTIMUM study: optimising immunisation using mixed schedules, an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule.

Authors:  James A Totterdell; Gladymar Perez Chacon; Marie J Estcourt; Mark Jones; Peter Richmond; Thomas L Snelling; Julie A Marsh
Journal:  Trials       Date:  2022-02-07       Impact factor: 2.279

6.  COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis.

Authors:  Aleksandra L Lindgren; Andrea Hui Austin; Kathleen M Welsh
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

7.  Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults.

Authors:  Jinhong Hu; Zhihui Chen; Jun Gu; Mobin Wan; Qian Shen; Marie-Paule Kieny; Jia He; Zhen Li; Qingfeng Zhang; Zarifah Hussain Reed; Yongmei Zhu; Wenjie Li; Yang Cao; Li Qu; Zhifang Cao; Qiang Wang; Haitao Liu; Xuegong Pan; Xiudong Huang; Dongmei Zhang; Xiangyang Xue; Weiqing Pan
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

8.  Safety of Tdap vaccine in pregnant women: an observational study.

Authors:  Helen Petousis-Harris; Tony Walls; Donna Watson; Janine Paynter; Patricia Graham; Nikki Turner
Journal:  BMJ Open       Date:  2016-04-18       Impact factor: 2.692

9.  Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation.

Authors:  Malini DeSilva; Flor M Munoz; Erick Sell; Helen Marshall; Alison Tse Kawai; Alisa Kachikis; Paul Heath; Nicola P Klein; James M Oleske; Fyezah Jehan; Hans Spiegel; Mirjana Nesin; Beckie N Tagbo; Anju Shrestha; Clare L Cutland; Linda O Eckert; Sonali Kochhar; Azucena Bardají
Journal:  Vaccine       Date:  2017-12-04       Impact factor: 3.641

10.  OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule.

Authors:  Gladymar Perez Chacon; Marie J Estcourt; James Totterdell; Dianne E Campbell; Kirsten P Perrett; Julie A Marsh; Peter C Richmond; Nicholas Wood; Michael S Gold; Patrick G Holt; Claire S Waddington; Thomas L Snelling
Journal:  BMJ Open       Date:  2020-12-17       Impact factor: 3.006
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.